ClearPoint Neuro (CLPT) Shares Outstanding (2011 - 2026)

ClearPoint Neuro's Shares Outstanding history runs 16 years deep, the most recent figure standing at $30.0 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 7.17% year-over-year to $30.0 million; the TTM figure through Mar 2026 stood at $30.0 million (up 7.17% YoY), while the FY2025 annual figure was $29.4 million, up 6.34% from the prior year.
• Shares Outstanding came in at $30.0 million for Q1 2026 at ClearPoint Neuro, up from $29.4 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $30.0 million in Q1 2026 to a low of $23.7 million in Q1 2022.
• A 5-year average of $26.4 million and a median of $26.0 million in 2023 frame the typical range for Shares Outstanding.
• Across the five-year window, Shares Outstanding gained 14.65% in 2022 and rose 0.3% in 2023, its largest moves.
• ClearPoint Neuro's Shares Outstanding stood at $24.6 million in 2022, then rose by 0.3% to $24.7 million in 2023, then grew by 12.03% to $27.6 million in 2024, then increased by 6.34% to $29.4 million in 2025, then increased by 2.1% to $30.0 million in 2026.
• According to Business Quant data, Shares Outstanding over the past three periods registered $30.0 million, $29.4 million, and $28.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison